BRUSSELS (Reuters) - EU antitrust regulators will widen a probe into Zimmer Holdings Inc's $13.4 billion bid for Biomet Inc but clear Eli Lilly's offer for a Novartis AG unit, three people familiar with the matter said on Thursday. The two deals are among several announced in recent months in the healthcare sector, with drugmakers seeking to gain scale or specialise in certain disease areas. ...
via Health News Headlines - Yahoo News http://ift.tt/1vcmxHy
No comments:
Post a Comment